Skip links

FusionQuest™

14 druggable fusion genes, regardless of cancer origin, in one cost-effective panel.

Key Features

Druggable Fusion Detection

All possible gene rearragment detections in 14 fusion genes, all treatable with target therapy.

3x Cheaper, 4x Simpler, and 5x Faster

All the benefits of NextAmp™ with actionable results.

Ideal for Screening

Affordable solution providing an option for screening of driver fusion mutations.

Report in 2 Hours

Simultaneously detect 14 druggable genes with unknown fusion partners. The report is generated in 2 hours.

Biomarker Content

12 Unknown Fusions

  • ALK
  • BRAF
  • ESR1
  • FGFR2
  • FGFR3
  • NTRK1
  • NTRK2
  • NTRK3
  • PDGFRA
  • PDGFRB
  • RET
  • ROS1

2 Mutations

  • EGFRvIII
  • MET

FusionQuest Analysis Workflow

Specifications

Talk to Our Expert

CTA - EN

Close Bitnami banner
Bitnami